Scopus BioPharma Inc.
SCPS · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,715 | -$26,953 | -$1,051 | -$2,690 |
| Dep. & Amort. | $2 | $2 | $1 | $1 |
| Deferred Tax | $0 | -$1,456 | $0 | $0 |
| Stock-Based Comp. | $352 | $670 | $290 | $214 |
| Change in WC | $3,235 | $2,841 | $1,149 | $355 |
| Other Non-Cash | $0 | $13,472 | -$2,915 | $0 |
| Operating Cash Flow | -$8,127 | -$11,425 | -$2,525 | -$2,120 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$2 | $0 | -$4 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$2 | -$2 | $0 | -$4 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$105 | $2,189 | $0 |
| Stock Issued | $0 | $20,100 | $3,274 | $1,777 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $242 | -$2,439 | -$1,110 | $407 |
| Financing Cash Flow | $242 | $17,557 | $4,353 | $2,184 |
| Forex Effect | $68 | -$19 | -$32 | -$24 |
| Net Chg. in Cash | -$7,818 | $6,111 | $1,795 | $35 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,943 | $1,832 | $37 | $2 |
| End Cash | $125 | $7,943 | $1,832 | $37 |
| Free Cash Flow | -$8,128 | -$11,427 | -$2,525 | -$2,125 |